Trial intelligence / Profile preview

PDS vs NACT in Stage IV Ovarian Cancer

NCT05371301Phase 3Unknown

Sponsor
Fudan University
Start
Jul 2021
Primary completion
Dec 2022
Modality
DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in Epithelial Ovarian Cancer (EOC), sponsored by Fudan University. Status: unknown.

02

Drugs

Paclitaxel Micelles for Injectioncarboplatin
03

Conditions

Epithelial Ovarian Cancer (EOC)

Beyond the preview

Go deeper on NCT05371301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05371301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call